Veterans Agency to offer new depression drug, despite cost and safety concerns

21 June 2019 - Confronted by a rising rate of suicides in some groups of veterans., the Department of Veterans ...

Read more →

Trump picks show over substance with drug price for veterans

14 June 2019 - His offer to help negotiate the price of a new J&J depression treatment is narrow in scope ...

Read more →

V.A. seeks to redirect billions of dollars into private care

12 January 2019 - The Department of Veterans Affairs is preparing to shift billions of dollars from government-run veterans’ hospitals ...

Read more →

Merck acknowledges the U.S. Department of Veterans Affairs for adopting biosimilar medicines to increase treatment options for veterans

4 October 2018 - Merck acknowledged the U.S. Department of Veterans Affairs for adopting biosimilar medicines as a means of ...

Read more →

The Institute for Clinical and Economic Review to collaborate with the Department of Veterans Affairs' Pharmacy Benefits Management Services Office

27 June 2017 - ICER drug assessment reports to support VA drug coverage and price negotiation with pharmaceutical companies to ...

Read more →

Donald Trump mulls ‘public-private’ care for veterans

2 January 2017 - Donald Trump could propose restructuring the Department of Veterans Affairs to allow veterans to purchase private ...

Read more →